MicroTest Laboratories Release: The Impact Of The Drug Quality And Security Act On Compounding Pharmacies Is The Subject Of May 13th Seminar In Boston

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

AGAWAM, Mass., April 29, 2014 (GLOBE NEWSWIRE) -- A seminar focusing on the impact of HR3204 — the Drug Quality and Security Act — on compound pharmacies and manufacturers is the subject of a seminar set for May 13, 2014 in Dedham, Mass., near Boston.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC